U S PHYSICAL THERAPY INC /NV (USPH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

U.S. Physical Therapy reported Q3 revenue growth of 13% to $223M, with EBITDA up 16% to $28M. The company reaffirmed its full-year EBITDA guidance of $102M-$106M. Growth was driven by increased physical therapy visits and hospital affiliations, while higher employee health benefit costs impacted margins.

U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 U.S. Physical Therapy November 5, 2026 Earnings Call 10:30 am ET Operator: Good day and thank you for standing by. Welcome to the U.S. Physical Therapy third quarter 2026 earnings call. At this time, all participants are in a listen-only mode. After the speaker’s pre

U.S. Physical Therapy (USPH) reported Q3 earnings, with adjusted physical therapy margins rising 60 basis points YoY to 19%, despite higher medical costs. The company plans acquisitions and clinic expansions. Industrial injury prevention revenue grew 14% to $33M. GAAP net income fell to $11M from $13M YoY. USPH ended Q3 with $38M in cash and $247M in borrowings.

U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit Houston, TX, November 4, 2026 – U.S. Phy

US Physical Therapy Inc (USPH) reported Q3 2026 revenue growth of 13% to $223M, driven by record patient visits and hospital affiliations. Net rate per visit hit $112, and EBITDA grew over 16%. The company reaffirmed full-year EBITDA guidance of $102M-$106M but faced higher self-insured group health costs and increased interest expenses. Management expects continued growth from hospital partnerships and cautious about medical cost trends.

U.S. Physical Therapy reported Q3 2026 revenue of $223M, up 13% YoY, with net income of $6M. Patient visits rose 8% to 1.7M, and revenue per visit hit $111. Adjusted EBITDA increased to $24M. The company declared a $0.46 dividend and reaffirmed its 2026 adjusted EBITDA guidance.